INGREDION INCORPORATED REPORTS THIRD QUARTER 2026 RESULTS

Ingredion Inc (INGR) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE Ingredion Incorporated CONTACTS: 5 Westbrook Corporate Center Investors: Noah Weiss, 773-896-5242 Westchester, IL 60154 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS THIRD QUARTER 2026 RESULTS • T&HS delivered its 10 th consecutive quarter of net sal

Event · Earnings
Also in this documentDividend · increase · $0.83Guidance · lower · $8.04–$8.49

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 5, 2026, 11:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INGR
Bearish
high confidence
Mentioned
$INGR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INGRBearishHigh
01

Why it matters

The earnings miss and lowered guidance are likely to trigger a sell‑off, though the company cites cost‑discipline initiatives.

02

Market read

The earnings release directly impacts INGR and may influence peers in the food‑ingredient space.

03

What to watch

Improved plant reliability and upcoming Tate & Lyle integration may offset short-term earnings weakness.

Relevance 7/10Novelty 8/10Timing: after-hours
AlphAI · Earnings readINGR · Third quarter 2026 · ended September 30, 2026

Ingredion Incorporated reports third quarter 2026 results: reported and adjusted operating income both decreased 19%, and reported and adjusted diluted EPS were $2.23 and $2.28.

↓Weak quarter

Third-quarter net sales decreased 1%, reported and adjusted operating income each decreased 19%, and reported and adjusted diluted EPS declined from $2.61 and $2.75 to $2.23 and $2.28. The Company lowered its full-year outlook, principally reflecting slower earnings recovery in Food & Industrial Ingredients – U.S./CAN, higher input costs and softer demand.

Revenue
$1.79B
(1%) y/y
Texture & Healthful Solutions net sales, three months ended September 30
$610M
1% y/y
EPS · non-GAAP
$2.28
Full-year 2026 outlook
Net sales to be flat; excluding results of the Pakistan business, net sales is expected to be flat to up low single digits.

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net sales, three months ended September 30GAAP$1.79B–(1%)
Net sales, nine months ended September 30GAAP$5.43B–(1%)
Gross profit, three months ended September 30GAAP$399M–(12%)
Gross profit, nine months ended September 30GAAP$1.23B–(12%)
Operating expenses, three months ended September 30GAAP$215M–6%
Operating expenses, nine months ended September 30GAAP$622M–3%
Operating income, three months ended September 30GAAP$201M–(19%)
Adjusted operating income, three months ended September 30non-GAAP$206M–(19%)
Operating income, nine months ended September 30GAAP$592M–(26%)
Adjusted operating income, nine months ended September 30non-GAAP$676M–(16%)
Net income, three months ended September 30GAAP$142M–(17%)
Net income attributable to Ingredion, three months ended September 30GAAP$142M–(17%)
Adjusted net income attributable to Ingredion, three months ended September 30non-GAAP$145M––
Net income, nine months ended September 30GAAP$402M–(29%)
Net income attributable to Ingredion, nine months ended September 30GAAP$398M–(29%)
Adjusted net income attributable to Ingredion, nine months ended September 30non-GAAP$475M––
Diluted EPS, three months ended September 30GAAP$2.23–(15%)
Adjusted diluted EPS, three months ended September 30non-GAAP$2.28––
Diluted EPS, nine months ended September 30GAAP$6.24–(28%)
Adjusted diluted EPS, nine months ended September 30non-GAAP$7.45––
Reported effective tax rate, three months ended September 30GAAP26.8%––
Adjusted effective tax rate, three months ended September 30non-GAAP26.4%––
Cash provided by operating activities, nine months ended September 30GAAP$389M––
Capital expenditures and mechanical stores purchases, nine months ended September 30GAAP−$313M––
Reported financing costs, three months ended September 30GAAP$5M––
Net adjusted financing costs, three months ended September 30non-GAAP$10M––

Segments

SegmentRevenueq/qy/y
Texture & Healthful Solutions net sales, three months ended September 30Volume growth of $12 million was partly offset by $(4) million of price mix and $(3) million of FX impact.$610M–1%
Food & Industrial Ingredients – LATAM net sales, three months ended September 30FX impact of $30 million and volume of $21 million were partly offset by $(12) million of price mix.$624M–7%
Food & Industrial Ingredients – U.S./Canada net sales, three months ended September 30Favorable price mix of $13 million was offset by volume of $(15) million and FX impact of $(1) million.$504M–(1%)
All Other net sales, three months ended September 30Pakistan volume of $(65) million from the sale of the majority stake in the Pakistan business was partially offset by volume of $3 million.$54M–(55%)
Texture & Healthful Solutions net sales, nine months ended September 30Volume of $69 million was partly offset by price mix of $(36) million.$1.85B–3%
Food & Industrial Ingredients – LATAM net sales, nine months ended September 30FX impact of $78 million and volume of $9 million were partly offset by price mix of $(27) million.$1.81B–3%
Food & Industrial Ingredients – U.S./Canada net sales, nine months ended September 30Volume of $(75) million and price mix of $(9) million drove the decline.$1.47B–(5%)
All Other net sales, nine months ended September 30Pakistan volume of $(65) million from the sale of the majority stake in the Pakistan business was partly offset by volume of $6 million and price mix of $5 million.$299M–(15%)

Full-year 2026 outlook

  • RevenueNet sales to be flat; excluding results of the Pakistan business, net sales is expected to be flat to up low single digits.
  • Tax rateReported effective tax rate of 27.9% to 28.9%; adjusted effective tax rate of 26.5% to 27.5%.
  • NoteReported diluted EPS of $8.04 to $8.49.
  • NoteAdjusted diluted EPS of $9.25 to $9.70.
  • NoteReported operating income expected to be down low double digits.
  • NoteAdjusted operating income expected to be down mid-teens.
  • NoteTexture & Healthful Solutions operating income expected to be flat to up low single-digits.
  • NoteFood & Industrial Ingredients – LATAM operating income anticipated to be down mid-to-high single-digits.
  • NoteFood & Industrial Ingredients – U.S./CAN operating income expected to be down 35-40%.
  • NoteAll Other operating loss anticipated to be approximately $(15) million.
  • NoteCorporate costs expected to be down mid-single-digits.
  • NoteCash from operations expected to be in the range of $650 million to $750 million.
  • NoteCapital expenditures expected to be approximately $450 to $490 million.
  • NoteGuidance reflects tariff levels in effect as of the end of October 2026.
  • NoteGuidance excludes acquisition-related integration and restructuring costs, as well as any potential impairment costs.

Capital returns

  • The Company paid $53 million in dividends to shareholders in the third quarter.
  • On September 17, 2026, the Company declared a quarterly dividend increase to $0.83 per share, which was paid on October 20, 2026.
  • Through September 30, the Company repurchased $85 million of common stock.
  • The Company is on track to complete its $100 million full-year share repurchase target.
  • Repurchases of common stock, net, were $(85) million for the nine months ended September 30, 2026, compared with $(134) million for the nine months ended September 30, 2025.
  • Dividends paid, including to non-controlling interests, were $(158) million for the nine months ended September 30, 2026, compared with $(157) million for the nine months ended September 30, 2025.

What drove it

  • Third-quarter net sales decreased 1%, primarily reflecting the sale of the majority stake in the Pakistan business.
  • Excluding results of the Pakistan business, net sales increased 2%, driven by favorable foreign exchange and higher volumes in Food & Industrial Ingredients – LATAM and Texture & Healthful Solutions.
  • Texture & Healthful Solutions delivered its 10th consecutive quarter of net sales volume growth, supported by continued strong demand for clean label globally.
  • Food & Industrial Ingredients – LATAM benefited from stronger volume from brewing and beverage customers in Mexico and Brazil.
  • Third-quarter reported and adjusted operating income were affected by higher input costs, manufacturing expense and softer food and beverage demand.
  • The $5 million difference between reported and adjusted operating income reflects acquisition-related costs, impairment charges and Argo thermal event costs, largely offset by a net restructuring benefit.
  • The third-quarter restructuring benefit was primarily from the gain on sale of land in Lane Cove, Australia.

Concerns

  • Argo’s slower than anticipated financial recovery was a primary reason third-quarter results fell short of expectations.
  • Food & Industrial Ingredients – U.S./CAN operating income declined 36%, driven by higher manufacturing expenses at the Argo facility and volume declines.
  • Texture & Healthful Solutions operating income declined 10%, driven by unfavorable tapioca costs, manufacturing expense and unfavorable price mix.
  • Food & Industrial Ingredients – LATAM operating income declined 6%, driven primarily by Mexico’s transactional currency impact and disruption from the earthquake in Colombia.
  • Consumer softness, higher input costs and lower price mix pressured the outlook.
  • The Company lowered its full-year outlook, primarily for the slower earnings recovery in Food & Industrial Ingredients – U.S./CAN, higher input costs and softer demand.

What to watch

  • Sustainable lowering of operating costs and improvement in volume growth at Argo following stable production for a second consecutive quarter and largely rebuilt inventories.
  • Whether Texture & Healthful Solutions can sustain net sales volume growth while absorbing higher tapioca costs and manufacturing input-cost inflation.
  • Food & Industrial Ingredients – U.S./CAN operating costs at Argo, where full-year operating income is expected to be down 35-40%.
  • Food & Industrial Ingredients – LATAM exposure to continued strength of the Mexican peso and recovery from the August earthquake in Colombia.
  • Cash from operations against the full-year range of $650 million to $750 million and capital expenditures against approximately $450 to $490 million.
  • Integration planning for the pending acquisition of Tate & Lyle.

Balance sheet and cash flow

  • At September 30, 2026, total debt was $1.8 billion and cash, including short-term investments, was $993 million, versus $1.8 billion and $1.0 billion at December 31, 2025.
  • Cash and cash equivalents were $989 million at September 30, 2026, compared with $1,030 million at December 31, 2025.
  • Short-term investments were $4 million at September 30, 2026, compared with $3 million at December 31, 2025.
  • Short-term borrowings were $533 million at September 30, 2026, compared with $48 million at December 31, 2025.
  • Long-term debt was $1,242 million at September 30, 2026, compared with $1,742 million at December 31, 2025.
  • Cash provided by operating activities was $389 million for the nine months ended September 30, 2026, compared with $539 million for the nine months ended September 30, 2025.
  • Cash used for investing activities was $(169) million for the nine months ended September 30, 2026, compared with $(302) million for the nine months ended September 30, 2025.
  • Capital expenditures and mechanical stores purchases were $(313) million for the nine months ended September 30, 2026, compared with $(299) million for the nine months ended September 30, 2025.
  • Proceeds from sales of businesses, net, were $139 million for the nine months ended September 30, 2026, compared with $12 million for the nine months ended September 30, 2025.
  • Cash used for financing activities was $(258) million for the nine months ended September 30, 2026, compared with $(340) million for the nine months ended September 30, 2025.

Analysis

Ingredion reported a weaker third quarter. Net sales were $1,792 million, down 1% from $1,816 million, while reported operating income decreased 19% to $201 million and adjusted operating income decreased 19% to $206 million. Reported diluted EPS was $2.23 compared with $2.61, and adjusted diluted EPS was $2.28 compared with $2.75. Gross profit declined 12% to $399 million, while operating expenses increased 6% to $215 million.

The sales result reflected the sale of the majority stake in the Pakistan business. Excluding Pakistan, net sales increased 2%, driven by favorable foreign exchange and higher volumes in Food & Industrial Ingredients – LATAM and Texture & Healthful Solutions. Texture & Healthful Solutions posted its 10th consecutive quarter of net sales volume growth and third-quarter net sales rose 1% to $610 million. Its operating income nevertheless declined 10% to $95 million because unfavorable tapioca costs, manufacturing expense and price mix more than offset volume and operating-expense benefits.

Food & Industrial Ingredients – U.S./Canada was the principal earnings pressure point. Third-quarter net sales decreased 1% to $504 million and operating income fell 36% to $52 million. Management cited higher manufacturing expenses at the Argo facility and volume declines, partly offset by favorable price mix. Food & Industrial Ingredients – LATAM delivered 7% sales growth to $624 million, but operating income decreased 6% to $109 million, with Mexico transactional currency impacts and the Colombia earthquake disruption more than offsetting higher volumes. All Other net sales fell 55% to $54 million, largely reflecting the Pakistan divestiture.

Cash generation was also lower through the first nine months. Cash provided by operating activities was $389 million compared with $539 million, while capital expenditures and mechanical stores purchases were $(313) million compared with $(299) million. At September 30, total debt was $1.8 billion and cash, including short-term investments, was $993 million. The Company paid $53 million in third-quarter dividends, repurchased $85 million of common stock through September 30 and declared a quarterly dividend increase to $0.83 per share.

The full-year outlook was reduced. Ingredion now expects reported diluted EPS of $8.04 to $8.49 and adjusted diluted EPS of $9.25 to $9.70. It expects net sales to be flat, reported operating income to be down low double digits and adjusted operating income to be down mid-teens. The guide explicitly reflects operational challenges in Food & Industrial Ingredients – U.S./CAN, where operating income is expected to decline 35-40%, as well as higher input costs and softer demand. Management expects cash from operations of $650 million to $750 million and capital expenditures of approximately $450 to $490 million.

Management, verbatim

Our third quarter results fell short of our expectations, largely due to Argo’s slower than anticipated financial recovery, with incremental pressure from higher input costs and consumer softness.

Jim Zallie, chairman, president and CEO of Ingredion

While production at Argo remained stable for a second consecutive quarter and inventories are largely rebuilt, high manufacturing costs coupled with softer food and beverage demand impacted profitable volume growth.

Jim Zallie, chairman, president and CEO of Ingredion

As a result, we are lowering our full-year outlook, primarily to reflect the slower earnings recovery in Food & Industrial Ingredients—U.S./CAN, along with the impacts of higher input costs and softer demand.

Jim Zallie, chairman, president and CEO of Ingredion

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Free cash flow was not reported.
  • Quarterly operating cash flow was not reported.
  • Prior-quarter comparisons were not reported for the presented metrics.
  • Quantitative gross-margin and operating-expense guidance was not reported.
  • Year-over-year percentage changes were not printed for adjusted net income, adjusted diluted EPS, effective tax rates, financing costs, or cash-flow line items.
  • The previous outlook covered the full year 2026 only, so there is nothing to compare for this quarter.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Ingredion Inc. (NYSE: INGR) filed a Form 8‑K reporting its Q3 2026 results and updated full‑year EPS outlook.

Company-level read

Ticker impact

$INGRBearishHigh confidence
Context

Ingredion reported Q3 2026 EPS fell and lowered full-year outlook to $8.04‑$8.49 reported EPS.

Expected impact

likely downside as investors price in weaker earnings outlook

Evidence & confidence

The filing shows a 19% drop in operating income and a cut to full-year EPS guidance, which typically triggers sell pressure.

Market effects

Ingredient solutions sector may see broader earnings scrutiny.

North American food ingredient suppliers could face margin pressure.

Limited to specialty ingredients niche.

Counterpoint

If cost controls succeed, the stock could rebound despite guidance cut.

Key entities

  • Jim Zallie

    Chairman, President and CEO of Ingredion

Every INGR earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$INGRMed

What Ingredion (INGR) Said on Its Q3 Earnings Call

Ingredion (INGR) reported Q3 earnings with mixed results. Texture & Healthful Solutions saw 2% volume growth but a 10% drop in operating income due to higher tapioca costs. Latin America segment faced currency impacts and earthquake disruptions. The company expects flat to low-single-digit operating income growth for the year and is progressing with its Tate & Lyle acquisition.

$INGRMed

Ingredion 3Q 2026: Revenue $1.79B, EPS $2.23 — 10-Q Summary

Ingredion reported 3Q 2026 revenue of $1.79B, down 1.3% YoY, and EPS of $2.23, down 14.6%. Net income fell 17% to $142M. Declines were attributed to lower gross profit, acquisition costs, and higher manufacturing expenses, partly offset by foreign exchange gains and higher volumes. Sales in most segments were impacted by various factors, including currency impacts and natural disasters.

$INGRMed

Ingredion (INGR) Q3 2026 Earnings Call Transcript

Ingredion (INGR) reported Q3 2026 earnings below expectations, with net sales up 2% excluding the Pakistan business sale. Higher manufacturing costs and a stronger Mexican peso pressured profitability. The company lowered its full-year outlook due to slower-than-expected profit recovery at Argo and cautious consumer demand views. Texture & Healthful Solutions saw 2% net sales volume growth, while Food & Industrial Ingredients LATAM grew 4%.

$INGRMed

Ingredion Incorporated Reports Third Quarter 2026 Results

Ingredion Incorporated (INGR) reported Q3 2026 results with net sales volume growth in T&HS but a 19% decrease in operating income. Diluted EPS was $2.23 (reported) and $2.28 (adjusted), down from $2.61 and $2.75 in Q3 2025. The company lowered full-year EPS guidance due to higher input costs and softer demand. CEO Jim Zallie cited Argo's slower recovery and manufacturing cost pressures as key challenges.